Last 6 hoursStory cluster

AstraZeneca's Baxfendy Gains FDA Approval for Hypertension

3 sources · 0 editorials5 factsMay 18 – May 19, 2026

Source coverage

Original publisher articles in this cluster. Broadside has not yet written editorial coverage.

FDA Approves AstraZeneca Drug With New Approach to Lowering High Blood Pressure

via MedCity News5 days ago

FDA approves AstraZeneca’s new kind of hypertension drug

via BioPharma Dive5 days ago

Why Real-World Evidence Is Becoming the Missing Link Between Innovation and Patient Care in Oncology

via MedCity News5 days ago

← Back to home